Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy-Reference-Cited by-同舟云学术

Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy

Published:2012-02-01 Issue:7 Volume:27 Page:2720-2733
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Álvarez-Prats Alejandro,Hernández-Perera Octavio,Díaz-Herrera Pilar,Ucero Álvaro C.,Anabitarte-Prieto Aránzazu,Losada-Cabrera Antonio,Ortiz Alberto,Rodríguez-Pérez José C.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/27/7/2720/17172103/gfr671.pdf

Reference60 articles.

1. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease;Brenner;Kidney Int,1983

2. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model;Floege;Lab Invest,1992

3. Nephropathic nature of proteinuria;Remuzzi;Curr Opin Nephrol Hypertens,1999

4. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney;Lee;J Clin Invest,1995

5. Focal glomerulosclerosis in the remnant kidney model—an inflammatory disease mediated by cytokines;Schiller;Nephrol Dial Transplant,1997

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simvastatin: a new therapeutic strategy for Chronic Kidney Disease (CKD);BALI MED J;2023

2. Nicousamide attenuates renal dysfunction and glomerular injury in remnant kidneys by inhibiting TGF-β1 internalisation and renin activity;European Journal of Pharmacology;2019-02

3. Tangeretin ameliorates renal failure via regulating oxidative stress, NF-κB–TNF-α/iNOS signalling and improves memory and cognitive deficits in 5/6 nephrectomized rats;Inflammopharmacology;2017-09-04

4. Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II–AT1 pathway in hypertensive nephropathy;Journal of Hypertension;2017-07

5. Designing drugs that combat kidney damage;Expert Opinion on Drug Discovery;2015-04-03